Pharsight

Drugs that contain Dronedarone Hydrochloride

1. Multaq patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8410167 SANOFI AVENTIS US Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
Apr, 2029

(5 years from now)

US9107900 SANOFI AVENTIS US Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality
Apr, 2029

(5 years from now)

US8602215 SANOFI AVENTIS US Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
Jun, 2031

(7 years from now)

Market Authorisation Date: 01 July, 2009

Treatment: Reduction in risk of hospitalization in patients with a history of paroxysmal or persistent af without severe heart failure and with one or more risk factors by administration twice a day with morning...

Dosage: TABLET;ORAL

How can I launch a generic of MULTAQ before it's drug patent expiration?
More Information on Dosage

MULTAQ family patents

Family Patents